$ARQT

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (1w)
Win rate (1w)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$ARQTSEC Form 4bearish
Sold 15,000 @ $26.33 avg · $394,897 · 2026-08-11

Form 4: Burnett Patrick sold ARQT

Burnett Patrick (See Remarks at Arcutis Biotherapeutics, Inc.) reported an open-market sale of 15,000 shares of ARQT at an average $26.33, roughly $394,897, in a Form 4 filed 2026-08-13.

View filing on SEC.gov →

End of results.